ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 954,48
1,85%
DAX
18 518,03
-0,44%
Brent Oil
83,35
-1,17%
Bitcoin
64 855,61
0,01%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
06/07/201216h56Dow Jones NewsRegistration Effectiveness Orders Issued by the SECNASDAQ:INSMInsmed Inc
06/07/201212h02Edgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:INSMInsmed Inc
02/07/201222h34Edgar (US Regulatory)Current report filing (8-K)NASDAQ:INSMInsmed Inc
02/07/201214h00PR Newswire (US)Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth CapitalNASDAQ:INSMInsmed Inc
27/06/201214h00PR Newswire (US)Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycob...NASDAQ:INSMInsmed Inc
15/06/201215h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
14/06/201222h33Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:INSMInsmed Inc
30/05/201214h00PR Newswire (US)Insmed Provides Corporate UpdateNASDAQ:INSMInsmed Inc
23/05/201214h00PR Newswire (US)Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculou...NASDAQ:INSMInsmed Inc
16/05/201214h00PR Newswire (US)Insmed Appoints Donald J. Hayden, Jr. as Executive ChairmanNASDAQ:INSMInsmed Inc
08/05/201214h09Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:INSMInsmed Inc
08/05/201213h00PR Newswire (US)Insmed Announces First Quarter 2012 Financial ResultsNASDAQ:INSMInsmed Inc
07/05/201214h00PR Newswire (US)Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis P...NASDAQ:INSMInsmed Inc
24/04/201214h00PR Newswire (US)Insmed to Host 2012 First Quarter Earnings Conference CallNASDAQ:INSMInsmed Inc
16/04/201214h00PR Newswire (US)Insmed Announces First Patient Dosed in Pivotal European Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with...NASDAQ:INSMInsmed Inc
10/04/201218h34Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:INSMInsmed Inc
13/03/201212h00PR Newswire (US)Insmed Announces Fourth Quarter and Full-Year 2011 Financial ResultsNASDAQ:INSMInsmed Inc
13/03/201211h31Edgar (US Regulatory)Annual Report (10-K)NASDAQ:INSMInsmed Inc
28/02/201214h00PR Newswire (US)Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference CallNASDAQ:INSMInsmed Inc
14/02/201220h27Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:INSMInsmed Inc
10/02/201214h00PR Newswire (US)Insmed Incorporated Provides Update on Clinical Program for ARIKACE®NASDAQ:INSMInsmed Inc
09/02/201219h13Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:INSMInsmed Inc
20/01/201214h00PR Newswire (US)Insmed Incorporated Provides Corporate UpdateNASDAQ:INSMInsmed Inc
14/11/201114h00PR Newswire (US)Insmed to Present at Lazard Capital Markets 8th Annual Healthcare ConferenceNASDAQ:INSMInsmed Inc
08/11/201113h00PR Newswire (US)Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2011NASDAQ:INSMInsmed Inc
25/10/201114h00PR Newswire (US)Insmed to Host 2011 Third Quarter Earnings Conference CallNASDAQ:INSMInsmed Inc
14/10/201114h00PR Newswire (US)Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria IndicationNASDAQ:INSMInsmed Inc
10/10/201114h00PR Newswire (US)Insmed Incorporated Provides Regulatory UpdateNASDAQ:INSMInsmed Inc
26/09/201114h00PR Newswire (US)Insmed to Present at Sixth Annual JMP Securities Healthcare ConferenceNASDAQ:INSMInsmed Inc
11/08/201114h00PR Newswire (US)Insmed to Present at 2011 Wedbush Securities Life Sciences Management Access ConferenceNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
ORA
Orange
EU
HO
Thales
EU
CS
Axa
EU
GLE
Societe Generale
NYSE
NKE
Nike
EU
DG
Vinci
EU
ML
Michelin
USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
EU
ACA
Credit Agricole
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés